HHV-8 positive Kaposi sarcoma in a patient with end-stage renal disease undergoing hemodialysis: No regressive effect of captopril

European Journal of Dermatology

Volumn 17, Issue 2, 2007, Pages 153-156

  Yaşar, Şirin ^a   Mansur, Ayse Tülin ^a   Göktay, Fatih ^a   Aydingöz, Ikbal Esen ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Captopril; End stage renal disease; Hemodialysis; Kaposi sarcoma

Indexed keywords

CAPTOPRIL; RAPAMYCIN;

AGED; ANAMNESIS; ANGIOGENESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HEMODIALYSIS; HERPES; HUMAN; HUMAN HERPESVIRUS 8; HYPERTENSION; IMMUNE DEFICIENCY; KAPOSI SARCOMA; KIDNEY FAILURE; KIDNEY GRAFT; MALE; SKIN TUMOR;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; DIAGNOSIS, DIFFERENTIAL; HERPESVIRUS 8, HUMAN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; SARCOMA, KAPOSI; SKIN NEOPLASMS; TREATMENT FAILURE;

EID: 33947432380     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2007.0130     Document Type: Article

References (24)

1. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000; 342: 1027-38.
2. Mendez JC, Procop GW, Espy MJ, Smith TF, McGregor CG, Paya CV. Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation. Transplantation 1999; 67: 1200-1.
3. Cattani P, Capuano M, Lesnoni La Parola I, Guido R, Santangelo R, Cerimele F, Masini C, Nanni G, Fadda G, Cerimele D. Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma. Arch Dermatol 1998; 134: 695-9.
4. Boneschi V, Brambilla L, Berti E, Ferrucci S, Corbellino M, Parravicini C, Fossati S. Human herpesvirus 8 DNA in the skin and blood of patients with Mediterranean Kaposi's sarcoma: clinical correlations. Dermatology 2001; 203: 19-23.
5. Nampoory MR, Johny KV, Sarkar C, Al-Masry I, Al-Hilali N, Anim JT. The dialysed patient with both Castleman disease and Kaposi sarcoma. Nephrol Dial Transplant 1998; 13: 2373-6.
6. Lebbe C. Human herpesvirus 8 as the infectious cause of Kaposi sarcoma: evidence and involvement of cofactors. Arch Dermatol 1998; 134: 736-8.
7. Herr H, Kim JU, Kang GH, Moon KC, Koh JK. Kaposi's sarcoma occurring during short-term dialysis: report of two cases. J Korean Med Sci 2001; 16: 130-4.
8. Metaxa-Mariatou V, Chiras T, Loli A, Gazouli M, Vallis D, Nasioulas G. Molecular analysis of Kaposi's sarcoma occurring during haemodialysis. Clin Exp Dermatol 2004; 29: 188-91.
9. Remuzzi G, Schieppati A, Minetti L. Hematologic consequences of renal failure. In: Brenner BM, Rector FC, eds. The Kidney. Philadelphia: Saunders, 2004: 2165-88.
10. Inamoto H, Ozaki R, Matsuzaki T, Wakui M, Saruta T, Osawa A. Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients. Nephron 1991; 59: 611-7.
11. Almuneef M, Nimjee S, Khoshnood K, Miller G, Rigsby MO. Prevalence of antibodies to human herpesvirus 8 (HHV-8) in Saudi Arabian patients with and without renal failure. Transplantation 2001; 71: 1120-4.
12. Luppi M, Vandelli L, Whitby D, Savazzi AM, Barozzi P, Medici G, Albertazzi A, Torelli G. Human herpesvirus-8 infection in hemodialysis patients from northern Italy. Kidney Int 1999; 55: 340.
13. Sheldon J, Henry S, Mourad M, Bodeus M, Squifflet JP, Schulz TF, et al. Human herpes virus 8 infection in kidney transplant patients in Belgium. Nephrol Dial Transplant 2000; 15: 1443-5.
14. Kallenberg CG, van der Laan S, de Zeeuw D. Captopril and the immune system. Lancet 1981; 11: 92.
15. De Albuquerque DA, Saxena V, Adams DE, Boivin GP, Brunner HI, Witte DP, Singh RR. An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. Kidney Int 2004; 65: 846-59.
16. Johnsen SA, Aurell M. Immunosuppressive action of captopril blocked by prostaglandin synthetase inhibitor. Lancet 1981; 1: 1005.
17. Puppin Jr. D, Rybojad M, de la Chapelle C, Morel P. Kaposi's sarcoma associated with captopril. Lancet 1990; 336: 1251-2.
18. Larbre JP, Nicolas JF, Collet P, Larbre B, Llorca G. Kaposi's sarcoma in a patient with rheumatoid arthritis possible responsibility of captopril in the development of lesions. J Rheumatol 1991; 18: 476-7.
19. Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molteni A, Polverini PJ, Bouck NP. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996; 98: 671-9.
20. Vogt B, Frey FJ. Inhibition of angiogenesis in Kaposi's sarcoma by captopril. Lancet 1997; 349: 1148.
21. Rao RD, Buckner JC, Sarkaria JN. Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents. Curr Cancer Drug Targets 2004; 4: 621-35.
22. Chen TG, Chen JZ, Wang XX. Effects of rapamycin on number activity and eNOS of endothelial progenitor cells from peripheral blood. Cell Prolif 2006; 39: 117-25.
23. Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002; 8: 128-35.
24. Gutierrez-Dalmau A, Sanchez-Fructuoso A, Sanz-Guajardo A, Mazuecos A, Franco A, Rial MC, Iranzo P, Torregrosa JV, Oppenheimer F, Campistol JM. Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma. Transplant Proc 2005; 37: 3836-8.